droxidopa
NDC 70436-141, droxidopa, capsule, from Slate Run Pharmaceuticals, LLC.
- Product NDC
- 70436-141
- Status
- Listed
- Labeler
- Slate Run Pharmaceuticals, LLC
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA215265
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70436-141 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DROXIDOPA200 mg/1
Pharmacologic classes
Catecholamines [CS]; Increased Blood Pressure [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70436-141-06 | 70436014106 | 90 CAPSULE in 1 BOTTLE (70436-141-06) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/049f997b-1649-467e-bbb9-bdb991b0bc6e
Use it
Look up 70436-141 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70436-141 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70436-141. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.